Imaging scan for lung cancer treatment response
Part of Cancer, Lungs & breathing clinical trials.
This trial uses a special imaging scan (SPECT/CT) with a radioactive tracer to see how well your NSCLC is responding to your first treatment. It may help doctors decide if the treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have non-small cell lung cancer (NSCLC) that cannot be removed by surgery.
- You have completed 2 to 4 cycles of your first cancer treatment and your disease has not grown or shrunk significantly.
- You have at least one tumor that can be measured on a scan.
- You have not had radiation to the chest or other tumors in the last 28 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET/CT scan that targets a protein called c-Met to help diagnose and stage non-small cell lung cancer. It aims to see if this imaging method can better identify tumor locations and characteristics.
This study uses special PET scans to see how well your immune cells respond to immunotherapy given before surgery for non-small cell lung cancer. The goal is to learn which patients benefit most from this treatment approach.
This trial tests if a special PET scan can show how your immune system responds to treatment before surgery. It is for people with early-stage lung cancer who are scheduled for surgery.
This trial tests whether a special PET/CT scan can show how well a Trop2-targeting drug is working in people with advanced lung cancer that has already been treated. It aims to improve how we monitor treatment response.
This trial uses a special imaging scan (SPECT/CT) with a small amount of radioactive tracer to look at prostate cancer. It aims to see how well the scan matches your prostate cancer tests and may help improve detection and assessment.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
Hear when a new NSCLC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.